2013
Cardio-Ankle Vascular Index in Subjects with Dyslipidaemia and Other Cardiovascular Risk Factors
SOŠKA, Vladimír; Michaela FRANTISOVÁ; Petr DOBŠÁK; Ladislav DUŠEK; Jiří JARKOVSKÝ et. al.Basic information
Original name
Cardio-Ankle Vascular Index in Subjects with Dyslipidaemia and Other Cardiovascular Risk Factors
Authors
SOŠKA, Vladimír (203 Czech Republic, guarantor, belonging to the institution); Michaela FRANTISOVÁ (203 Czech Republic, belonging to the institution); Petr DOBŠÁK (203 Czech Republic, belonging to the institution); Ladislav DUŠEK (203 Czech Republic, belonging to the institution); Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution); Marie NOVÁKOVÁ (203 Czech Republic, belonging to the institution); Kohji SHIRAI (392 Japan); Lenka FAJKUSOVÁ (203 Czech Republic, belonging to the institution) and Tomáš FREIBERGER (203 Czech Republic, belonging to the institution)
Edition
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, TOKYO, JAPAN ATHEROSCLEROSIS SOC, 2013, 1340-3478
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
Japan
Confidentiality degree
is not subject to a state or trade secret
Impact factor
Impact factor: 2.770
RIV identification code
RIV/00216224:14110/13:00070319
Organization unit
Faculty of Medicine
UT WoS
000328731700003
Keywords in English
Dyslipidaemia; Cardio-ankle vascular index; Hypertension; Diabetes mellitus; Smoking
Tags
International impact, Reviewed
Changed: 29/4/2014 14:24, Ing. Mgr. Věra Pospíšilíková
Abstract
V originále
Aim: The cardio-ankle vascular index (CAVI) is a novel non-invasive marker of arterial stiffness and atherosclerosis. The aim of this work was to examine whether the CAVI value in patients with dyslipidaemia (DLP) is increased by the presence of other cardiovascular risk factors: hypertension, diabetes mellitus, and smoking. Methods: A total of 392 subjects with DLP (166 male, 226 female), with a median age of 58.5 and 5-95 percentile range 32.2-73.9 years were examined. CAVI was measured using the VaSera 1500 system. Results: CAVI correlated significantly with age (p<0.001) and both systolic (p<0.001) and diastolic (p=0.002) blood pressure; higher values were found in men (p=0.034) than in women in the 56-65 age group. There was no significant difference in CAVI between smokers and non-smokers (p=0.217) and between subjects with and without diabetes mellitus (p=0.424). CAVI was significantly higher in subjects with hypertension than in the normotensive group (p<0.001) and in statin-treated subjects than in those without statins (p<0.001); however, CAVI values adjusted for age and sex did not differ significantly between these groups. Adjusted CAVI values were higher only in smokers than in non-smokers (former smokers) (p<0.001). Conclusion: The study proves conclusively that the CAVI value in DLP patients is not significantly affected by hypertension and diabetes mellitus, but it is increased by smoking.